Zevra Therapeutics to Report Fourth Quarter and Full-Year

Zevra Therapeutics to Report Fourth Quarter and Full-Year

CELEBRATION, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: KMPH) (Zevra, or the Company, formerly KemPharm, Inc.), a rare......

menu
menu